The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease

FENO increases in patients with stable COPD. ICS therapy decreased elevated FENO levels in these patients without statistically significant changes in lung function. The selection of COPD patients with increased FENO level and partial reversibility of airway obstruction should be helpful in terms of proposed ICS treatment.